How much do beta blockers help after a heart attack, even when the heart’s pumping well? In this episode, we revisit the origins of beta blockers in post-MI care, examine how evidence evolved, and explore the REDUCE-AMI trial, which questions whether beta blockers are still needed for all.
Listen to this latest episode of Beyond Journal Club, a collaboration between Core IM and NEJM Group, where we put research into context tracing the arc of evidence, dissecting the clinical question, and exploring what the findings could mean for real-world patient care
🔹 Sponsor: NEJM Fellowship Program, click here to learn more and/or apply!
Timestamps:
(00:48) | Background on Beta Blockers and Their Mechanism
(02:41) | Historical Context of Beta Blockers in Heart Disease
(04:56) | Capricorn Trial and Its Impact
(07:17) | Emergence of Doubts About Beta Blockers
(10:09) | Introduction to the REDUCED-AMI Trial
(15:52) | Discussion on Trial Interpretation and Clinical Implications
(16:18) | Comparison with Other Trials and Future Directions
Tags: CoreIM, Internal Medicine, Primary Care, Medical Education, IMCore, Physician Assistant, Nurse Practitioner, Medical Student, Cardiology